Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| GSK plc | 9.19M | $20.0M | 15.81% | -- | 2026-06-30 |
| Pfizer Inc | 2.36M | $5.0M | 4.06% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.04M | $4.0M | 3.50% | +236.3K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 947.9K | $2.0M | 1.63% | -241.3K | 2026-06-30 |
| Alphabet Inc. | 890.0K | $1.0M | 1.53% | -- | 2026-06-30 |
| BlackRock, Inc. | 594.4K | $1.0M | 1.02% | +161.2K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 566.3K | $1.0M | 0.97% | +46.4K | 2026-06-30 |
| RAYMOND JAMES FINANCIAL INC | 521.7K | $1.0M | 0.90% | +518.6K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 382.8K | -- | 0.66% | -- | 2026-06-30 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 333.0K | -- | 0.57% | +182.5K | 2026-06-30 |
